Skip to main content
. 2018 Feb 1;8(2):291–301.

Figure 2.

Figure 2

miR-1294 suppresses glioma cell proliferation, migration, and invasion and enhances chemosensitivity to temozolomide in vitro. A. qRT-PCR analysis of miR-1294 expression in U87 and U251 cells transfected with NC or miR-1294 mimic. B, C. The CCK-8 assay for U87 and U251 cells transfected with NC or miR-1294 mimic. D. The migration assay for U87 and U251 cells transfected with NC or miR-1294 mimic. E. The Transwell assay for U87 and U251 cells transfected with NC or miR-1294 mimic. F, G. Cell viability was examined for U87 and U251 cells transfected with NC or miR-1294 mimic following TMZ treatments at various doses. H, I. Cell viability was examined every 24 hours for U87 and U251 cells transfected with NC or miR-1294 mimic following TMZ treatments at the indicated concentrations. *P<0.05, **P<0.01.